HeartFlow, Inc.

At HeartFlow, we are revolutionizing precision heart care by uniquely combining human ingenuity with advanced technology. Through groundbreaking technology, we are transforming how coronary artery disease (CAD) – the world's leading cause of death – is diagnosed and treated. Our AI-driven platform creates a personalized, precision 3D model of the heart from a single CT scan. This provides clinicians with unprecedented clarity and confidence to deliver earlier, more effective treatments, ultimately transforming CAD into a disease that can be managed for life. The HeartFlow Analysis leverages artificial intelligence and highly trained analysts to create these digital 3D models of a patient's coronary arteries. This interactive, color-coded model enables physicians to better evaluate the impact a coronary blockage has on blood flow and determine the optimal treatment path for each patient.

Since our inception, we've developed innovative solutions inspired and guided by intelligence, from AI-powered 3D modeling of the heart to data-driven insights that reshape how CAD is detected, understood, and managed. We partner closely with clinicians and healthcare teams to improve patient experiences and create personalized, efficient care pathways, all leading to the best possible outcomes for patients. The HeartFlow Analysis is a non-invasive, personalized cardiac test for stable symptomatic patients with CAD. Our technology uses data from standard computerized tomography scans to create these detailed models and analyzes the impact of blockages on blood flow, enabling clinicians to treat patients with significant coronary artery disease while reducing unnecessary invasive testing. We are committed to advancing coronary care by empowering clinicians with precision tools and insights to optimize care delivery. HeartFlow is positioned at the intersection of AI and healthcare, leveraging deep learning, cloud computing, and computational fluid dynamics as foundational elements driving the continuous evolution of our products. Our goal is to set a new standard of care for diagnosing cardiovascular disease worldwide.